IRIS
PAOLINO, SABRINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.518
AS - Asia 3.054
NA - Nord America 2.868
SA - Sud America 308
AF - Africa 54
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 21.805
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.088
US - Stati Uniti d'America 2.692
SG - Singapore 1.193
CN - Cina 747
VN - Vietnam 541
BD - Bangladesh 254
BR - Brasile 196
FR - Francia 184
HK - Hong Kong 131
CA - Canada 72
AR - Argentina 53
FI - Finlandia 50
DE - Germania 45
MX - Messico 44
ID - Indonesia 35
GB - Regno Unito 33
IN - India 29
JP - Giappone 29
NL - Olanda 18
JM - Giamaica 17
ZA - Sudafrica 17
PH - Filippine 16
CO - Colombia 15
IQ - Iraq 15
EC - Ecuador 13
ES - Italia 11
PL - Polonia 11
TR - Turchia 11
CH - Svizzera 10
SE - Svezia 10
MA - Marocco 9
PY - Paraguay 9
VE - Venezuela 9
CL - Cile 8
RU - Federazione Russa 7
UA - Ucraina 7
CR - Costa Rica 6
GT - Guatemala 6
NI - Nicaragua 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
BE - Belgio 5
EG - Egitto 5
KR - Corea 5
PR - Porto Rico 5
TN - Tunisia 5
UZ - Uzbekistan 5
HN - Honduras 4
HR - Croazia 4
HU - Ungheria 4
IE - Irlanda 4
KE - Kenya 4
LT - Lituania 4
PT - Portogallo 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BS - Bahamas 3
BY - Bielorussia 3
IL - Israele 3
KG - Kirghizistan 3
PK - Pakistan 3
RO - Romania 3
TW - Taiwan 3
AG - Antigua e Barbuda 2
AL - Albania 2
AT - Austria 2
AU - Australia 2
BB - Barbados 2
DK - Danimarca 2
DZ - Algeria 2
KH - Cambogia 2
MY - Malesia 2
NG - Nigeria 2
NP - Nepal 2
PE - Perù 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AM - Armenia 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
CD - Congo 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GR - Grecia 1
IR - Iran 1
JO - Giordania 1
KW - Kuwait 1
ML - Mali 1
MR - Mauritania 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
Totale 21.802
Salva come PNG Salva come JPEG
Città #
Genova 6.506
Genoa 6.062
Vado Ligure 1.188
Rapallo 1.038
Singapore 583
San Jose 511
St Louis 283
Ashburn 249
Ho Chi Minh City 169
Lauterbourg 167
Hanoi 138
New York 137
Council Bluffs 136
Beijing 135
Hong Kong 128
Los Angeles 69
Boardman 55
Bordighera 47
Helsinki 40
Santa Clara 38
Milan 33
Chicago 32
Mexico City 31
Frankfurt am Main 27
Tokyo 24
Haiphong 23
Orem 22
Atlanta 19
Buffalo 18
Da Nang 17
Dallas 16
Phoenix 16
Rome 16
Montreal 15
Kingston 13
Amsterdam 12
City of London 12
Houston 12
Biên Hòa 11
Naples 11
São Paulo 11
Tianjin 11
Brooklyn 10
Denver 10
Hải Dương 10
Lappeenranta 10
Padua 10
Jamaica Plain 9
Las Vegas 9
Philadelphia 9
Rio de Janeiro 9
Thái Nguyên 9
Warsaw 9
Washington 9
Zurich 9
Charlotte 8
Johannesburg 8
Miami 8
Salt Lake City 8
San Francisco 8
Thái Bình 8
Toronto 8
Waltham 8
Baghdad 7
Can Tho 7
Jakarta 7
Newark 7
Stockholm 7
Bắc Giang 6
Detroit 6
Jacksonville 6
Managua 6
Mumbai 6
Nuremberg 6
Paris 6
Queens 6
Boydton 5
Columbus 5
Des Moines 5
Fresno 5
Guatemala City 5
Medford 5
Ninh Bình 5
Quito 5
Quận Ba 5
Tashkent 5
Ankara 4
Baltimore 4
Bari 4
Bogotá 4
Bắc Ninh 4
Calgary 4
Chennai 4
Cincinnati 4
Curitiba 4
Dhaka 4
Dublin 4
Goiânia 4
Hangzhou 4
La Plata 4
Totale 18.456
Salva come PNG Salva come JPEG
Nome #
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts 237
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. 235
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents 226
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay 217
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study 214
Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments. 203
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. 200
Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. 197
Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy 197
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis 196
Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages 193
Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis 191
Idiopathic inflammatory myopathies: narrative review of unmet needs in clinical practice guidelines 188
Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS). 187
Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis. 183
Correlation between bone quality and microvascular damage in systemic sclerosis patients 182
Ehlers-Danlos syndromes: state of the art on clinical practice guidelines. 182
Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients. 182
Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study 181
Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients 177
Quantitative Alterations of Capillary Diameter Have a Predictive Value for Development of the Capillaroscopic Systemic Sclerosis Pattern 177
Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients 174
Advanced in naifold capillaroscopic analysis in systemic sclerosis 171
Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: Proof of principle and validation in systemic sclerosis 169
Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis 168
Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages 167
Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon 163
Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review. 163
A method for counting monosodium urate crystals in synovial fluid 162
Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. 162
Anti-TNF and sex hormones 161
Aromatase inhibitor-induced bone loss osteosarcopenia in older patients with breast cancer: effects of the RANK/RANKL system’s inhibitor denosumab vs. bisphosphonates 157
Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients 157
Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis. 153
Progression of Organ Involvement in Systemic Sclerosis Patients with Persistent "Late" Nailfold Capillaroscopic Pattern of Microangiopathy: A Prospective Study. 149
Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis. 148
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis. 148
CTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression 148
Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells 148
CTLA-4 blockade in the treatment of rheumatoid arthritis: an update 147
Metabolic Profile and Bone Status in Post-Menopausal Women with Rheumatoid Arthritis: A Monocentric Retrospective Survey 146
Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey 144
Lower urinary tract symptoms in systemic sclerosis: a detailed investigation. 143
Systemic lupus erythematosus: state of the art on clinical practice guidelines 142
Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients 141
[Role of videocapillaroscopy in early detection of transition from primary to secondary Raynaud's phenomenon in systemic sclerosis]. 139
BONE MINERAL DENSITY AND SEASONAL VARIATIONS IN BONE TURNOVER IN SYSTEMIC SCLEROSIS PATIENTS 139
Primary Raynaud's phenomenon and nailfold videocapillaroscopy: age-related changes in capillary morphology. 139
Osteoporosis in the elderly. 139
Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? 137
Inflammatory gene profile in early rheumatoid arthritis and modulation by leflunomide and prednisone treatment. 137
Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosus. 136
PLASMA VITAMIN D LEVELS IN RELATION TO INSULIN RESISTANCE AND RISK OF METABOLIC SYNDROME IN RHEUMATOID ARTHRITIS PATIENTS 135
RHEUMATOID VERSUS PSORIATIC ARTHRITIS: SIMILAR OR DIFFERENT BONE LOSS? 135
Vitamin D in rheumatoid arthritis. 135
Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. 134
Vitamin D, steroid hormones, and autoimmunity. 133
New Kids on the Block in SSc-PAH: May We Futurely Nail It Additionally Down to Capillaroscopy? A Systematic Literature Review 130
Prevalence of hybrid TLR4+M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease 130
Assessment of the plantar pressure and its correlation with the disease progression in patients with rheumatoid arthritis | [Valutazione della pressione plantare e correlazione con l'attività di malattia nei pazienti con artrite reumatoide] 129
Capillaroscopy 2016: new perspectives in systemic sclerosis. 128
Glucocorticoid management in rheumatoid arthritis: Morning or night low dose? 128
Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study 127
Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis. 127
Body Composition and Bone Status in Relation to Microvascular Damage in Systemic Sclerosis Patients 127
Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings 127
Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease 125
A Systematic Review of Aminaphtone from Pathophysiology to Clinical Applications: Focus on New Rheumatological Acquisitions 125
Microvascular damage evaluation in systemic sclerosis: the role of nailfold videocapillaroscopy and laser techniques. 124
The epigenetic effects of glucocorticoids, sex hormones and vitamin D as steroidal hormones in rheumatic musculoskeletal diseases 123
Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms 123
The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis 123
VITAMIN D LEVELS AND BONE LOSS IN SYSTEMIC SCLEROSIS 122
Interaction between microbiota , diet/nutrients and immune/inflammatory response in rheumatic disease: focus on rheumatoid artrthris 121
Advanced microvascular damage associated with occurence of sarcopenia in systemic sclerosis patients: results from a retrospective cohort study. 121
High-resolution Doppler ultrasound in systemic sclerosis: Analysis of digital arteries and nailfold microvasculature using 18-5 MHz and 33-9 MHz probes 119
Use of glucocorticoids and risk of infections. 119
VITAMIN D SERUM LEVELS CORRELATE WITH BONE MASS VALUES IN POSTMENOPAUSAL SYSTEMIC SCLEROSIS PATIENTS 118
AB0292 BONE MINERAL DENSITY (BMD), BONE TURNOVER MARKERS (BTMS) AND EVALUATION OF MUSCULOSKELETAL SYSTEM IN PATIENTS WITH DIFFERENTIATED THYROID CANCER UNDERGOING TSH SUPPRESSIVE THERAPY 117
The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review 117
Vitamin D and COVID-19: Narrative Review after 3 Years of Pandemic 116
Nailfold capillaroscopic parameters and skin telangiectasia patterns in patients with systemic sclerosis. 116
Comment on: Lower urinary tract symptoms in systemic sclerosis patients: a detailed investigation: reply. 116
Institution of an interdisciplinary IBD centre is associated with improved healthcare utilisation 114
Vitamin D, inflammation and immunity: review of literature and considerations on recent translational and clinical research developments 114
RELATIONSHIPS BETWEEN BONE LOSS AND DICKKOPF-1 (DKK-1) SERUM LEVELS IN PATIENTS WITH SYSTEMIC SCLEROSIS 113
CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients 113
Role of endothelin-1 on cell growth and fibrogenesis by primari cultures of human fibroblast: the effects of sex hormones 112
Peripheral and ocular microvascular alterations in systemic sclerosis: observations from capillaroscopic assessments, perfusion peripheral analysis, and optical coherence tomography angiography 111
Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. 110
Are there any positive effects of TNF-alpha blockers on bone metabolism? 110
Effects of anti-TNFα treatment on lipid profile in patients with active rheumatoid arthrits 109
Possible contribution of chronic inflammation in the induction of cancer in rheumatic diseases 108
Full longitudinal nailfold videocapillaroscopy analysis of microvascular changes during normal pregnancy 108
Nailfold videocapillaroscopy in juvenile dermatomyositis: detailed correlations between microvascular abnormalities with clinical and laboratory parameters from an observational retrospective single-center study 107
The paradox of ankylosing spondylitis: Concomitant osteoporosis and new bone formation 107
Correction: Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity 103
Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis. 103
Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update 102
Capillaroscopic analysis of the microvascular status in mixed versus undifferentiated connective tissue disease. 102
Totale 14.558
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.932
article - articoli 71.207
book - libri 0
conference - conferenze 2.101
curatela - curatele 0
other - altro 342
patent - brevetti 0
selected - selezionate 0
volume - volumi 282
Totale 147.864
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.422 60 69 83 164 39 97 111 332 111 122 70 164
2022/20231.282 144 93 27 90 196 173 21 105 207 25 175 26
2023/20241.096 35 125 17 129 51 204 77 115 37 34 68 204
2024/20253.149 135 208 104 186 408 298 292 508 108 234 340 328
2025/20269.432 936 491 777 1.284 1.041 696 1.187 373 772 938 477 460
2026/2027710 710 0 0 0 0 0 0 0 0 0 0 0
Totale 22.560